Atlas Trials

Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment

Clinical trial NCT04435964 · COMPLETED

Trial details

NCT number
NCT04435964
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
COMPLETED
Study type
OBSERVATIONAL
MelanomaLung CancerHead and Neck CancerUrogenital NeoplasmsBreast Cancer
Start date
2020-06-25
Primary completion
2023-02-28
Enrollment
247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.